Retracted

• Samah Elsaadi,
• Kristine Misund,
• Pegah Abdollahi,
• Esten Nymoen Vandsemb,
• Siv Helen Moen,
• Anna Kusnierczyk,
• Geir Slupphaug,
• Therese Standal,
• Anders Waage,
• Tobias S Slørdahl,
• Even Rustad,
• Anders Sundan,
• Carl Hay,
• Alwin G Schuller,
• Alexandra Borodovsky,
• Eline Menu,
• Magne Børset,
• Anne Marit Sponaas

Affiliations

Samah Elsaadi

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Kristine Misund

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Pegah Abdollahi

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Esten Nymoen Vandsemb

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Siv Helen Moen

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Anna Kusnierczyk

PROMEC, Department for Clinical and Molecular Medicine, NTNU, Trondheim, Norway

Geir Slupphaug

PROMEC, Department for Clinical and Molecular Medicine, NTNU, Trondheim, Norway

Therese Standal

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Anders Waage

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Tobias S Slørdahl

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Even Rustad

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Anders Sundan

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Carl Hay

Oncology R&D, AstraZeneca Medimmune, Gaithersburg, Maryland, USA

Alwin G Schuller

Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts, USA

Alexandra Borodovsky

Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts, USA

Eline Menu

Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Brussel, Massachusetts, Belgium

Magne Børset

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

Anne Marit Sponaas

Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway